BNN logo

BRAIN Biotech AG Stock Price

XTRA:BNN Community·€52.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

BNN Share Price Performance

€2.42
-0.89 (-26.89%)
€2.42
-0.89 (-26.89%)
Price €2.42

BNN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Reasonable growth potential with low risk.

3 Risks
2 Rewards

BRAIN Biotech AG Key Details

€51.3m

Revenue

€21.4m

Cost of Revenue

€29.9m

Gross Profit

€41.7m

Other Expenses

-€11.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 25, 2026
-0.54
58.34%
-22.88%
255.6%
View Full Analysis

About BNN

Founded
1993
Employees
300
CEO
Adriaan Moelker
WebsiteView website
www.brain-biotech.com

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Recent BNN News & Updates

Recent updates

No updates